Lyka Labs Ltd.
LYKALABS Share PricePharmaceuticals & Drugs
₹81.16
-2.4 (-2.9%)
As on December 4, 2025
Exchange Scrips: BSE500259NSELYKALABSISININE933A01014
Market Cap ₹ 288 Cr
P/E Ratio 36.15
Dividend Yield N/A
Performance
Market performance
Open82.7
High84.19
Volumes18,968
Prev81.16
Low80.5
As on2025-12-04
Historical performance
1 Year High176.59
3 Year High176.59
5 Year High267
1 Year Low79.06
3 Year Low79.06
5 Year Low19.05
Fundamentals
Company Valuation
Market Cap (₹Cr)
288
Face Value (₹)
10
P/E Ratio
36.15
Dividend Yield
N/A
Investment Returns
1 Year
-50.7%
3 Years
-41%
5 Years
261.5%
10 Years
-31.6%
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 82.15 | Bearish |
| 10-DMA | 82.28 | Bearish |
| 20-DMA | 85.1 | Bearish |
| 50-DMA | 91.32 | Bearish |
| 100-DMA | 98.01 | Bearish |
| 200-DMA | 104.79 | Bearish |
Shareholding Pattern
| Field | Sep-2025 | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 |
|---|---|---|---|---|---|
| Promoters | 14 | 14 | 12 | 10 | 10 |
| Foreign Investors | --- | --- | --- | --- | --- |
| Domestic Investors | 14 | 14 | 12 | 10 | 10 |
| Public Investors | 27729 | 28175 | 28460 | 29089 | 28933 |
| Government | --- | --- | --- | --- | --- |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 36.15.
- 3Y Stock Price CAGR of the stock is -15.9.
- The stock has a beta of 0.9.
- In the last financial year, the company had an EBITDA of ₹202 Million.
- The company generated revenue of ₹1385 Million in the previous financial year.
Lyka Labs Ltd.
81.16-2.4 (-2.9%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 486250.1
No. of Shares: 5991 (Approx)
Performance:-51.4%
P/L: ₹-513749.9
Top Gainers
Peer Comparison
Get Your Portfolio Reviewed
